Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound

Abstract The spectrum of activity and mode of action of a novel antibacterial agent, 135C, was investigated using a range of microbiological and genomic approaches. Compound 135C was active against Gram-positive bacteria with MICs for Staphylococcus aureus ranging from 0.12–0.5 μg/ml. It was largely...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikki Y. T. Man, Daniel R. Knight, Scott G. Stewart, Allan J. McKinley, Thomas V. Riley, Katherine A. Hammer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6225b1808d5240eb86f682657bc68d98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6225b1808d5240eb86f682657bc68d98
record_format dspace
spelling oai:doaj.org-article:6225b1808d5240eb86f682657bc68d982021-12-02T16:07:51ZSpectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound10.1038/s41598-018-25080-w2045-2322https://doaj.org/article/6225b1808d5240eb86f682657bc68d982018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25080-whttps://doaj.org/toc/2045-2322Abstract The spectrum of activity and mode of action of a novel antibacterial agent, 135C, was investigated using a range of microbiological and genomic approaches. Compound 135C was active against Gram-positive bacteria with MICs for Staphylococcus aureus ranging from 0.12–0.5 μg/ml. It was largely inactive against Gram-negative bacteria. The compound showed bacteriostatic activity in time-kill studies and did not elicit bacterial cell leakage or cell lysis. Checkerboard assays showed no synergy or antagonism when 135C was combined with a range of other antibacterials. Multi-step serial passage of four S. aureus isolates with increasing concentrations of 135C showed that resistance developed rapidly and was stable after drug-free passages. Minor differences in the fitness of 135C-resistant strains and parent wildtypes were evident by growth curves, but 135C-resistant strains did not show cross-resistance to other antibacterial agents. Genomic comparison of resistant and wildtype parent strains showed changes in genes encoding cell wall teichoic acids. 135C shows promising activity against Gram-positive bacteria but is currently limited by the rapid resistance development. Further studies are required to investigate the effects on cell wall teichoic acids and to determine whether the issue of resistance development can be overcome.Nikki Y. T. ManDaniel R. KnightScott G. StewartAllan J. McKinleyThomas V. RileyKatherine A. HammerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nikki Y. T. Man
Daniel R. Knight
Scott G. Stewart
Allan J. McKinley
Thomas V. Riley
Katherine A. Hammer
Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
description Abstract The spectrum of activity and mode of action of a novel antibacterial agent, 135C, was investigated using a range of microbiological and genomic approaches. Compound 135C was active against Gram-positive bacteria with MICs for Staphylococcus aureus ranging from 0.12–0.5 μg/ml. It was largely inactive against Gram-negative bacteria. The compound showed bacteriostatic activity in time-kill studies and did not elicit bacterial cell leakage or cell lysis. Checkerboard assays showed no synergy or antagonism when 135C was combined with a range of other antibacterials. Multi-step serial passage of four S. aureus isolates with increasing concentrations of 135C showed that resistance developed rapidly and was stable after drug-free passages. Minor differences in the fitness of 135C-resistant strains and parent wildtypes were evident by growth curves, but 135C-resistant strains did not show cross-resistance to other antibacterial agents. Genomic comparison of resistant and wildtype parent strains showed changes in genes encoding cell wall teichoic acids. 135C shows promising activity against Gram-positive bacteria but is currently limited by the rapid resistance development. Further studies are required to investigate the effects on cell wall teichoic acids and to determine whether the issue of resistance development can be overcome.
format article
author Nikki Y. T. Man
Daniel R. Knight
Scott G. Stewart
Allan J. McKinley
Thomas V. Riley
Katherine A. Hammer
author_facet Nikki Y. T. Man
Daniel R. Knight
Scott G. Stewart
Allan J. McKinley
Thomas V. Riley
Katherine A. Hammer
author_sort Nikki Y. T. Man
title Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
title_short Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
title_full Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
title_fullStr Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
title_full_unstemmed Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
title_sort spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/6225b1808d5240eb86f682657bc68d98
work_keys_str_mv AT nikkiytman spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
AT danielrknight spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
AT scottgstewart spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
AT allanjmckinley spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
AT thomasvriley spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
AT katherineahammer spectrumofantibacterialactivityandmodeofactionofanoveltrisstilbenebacteriostaticcompound
_version_ 1718384719750496256